However, the combined knockdown of PVT1 and p53 counteracted the suppressive effects of p53 on TGF-β activity, indicating that p53 attenuated the TGF-β/SMAD pathway in GBM by targeting PVT1 [94]. The gene discussed is TP53; the disease is glioblastoma.